BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22351710)

  • 1. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3.
    Malinoc A; Sullivan M; Wiech T; Schmid KW; Jilg C; Straeter J; Deger S; Hoffmann MM; Bosse A; Rasp G; Eng C; Neumann HP
    Endocr Relat Cancer; 2012 Jun; 19(3):283-90. PubMed ID: 22351710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
    Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
    Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome.
    Gaal J; van Nederveen FH; Erlic Z; Korpershoek E; Oldenburg R; Boedeker CC; Kontny U; Neumann HP; Dinjens WN; de Krijger RR
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4367-71. PubMed ID: 19808854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association.
    Hernandez KG; Ezzat S; Morel CF; Swallow C; Otremba M; Dickson BC; Asa SL; Mete O
    Virchows Arch; 2015 Jun; 466(6):727-32. PubMed ID: 25800244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*).
    Bickmann JK; Sollfrank S; Schad A; Musholt TJ; Springer E; Miederer M; Bartsch O; Papaspyrou K; Koutsimpelas D; Mann WJ; Weber MM; Lackner KJ; Rossmann H; Fottner C
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E489-96. PubMed ID: 24423348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline SDHB mutations and familial renal cell carcinoma.
    Ricketts C; Woodward ER; Killick P; Morris MR; Astuti D; Latif F; Maher ER
    J Natl Cancer Inst; 2008 Sep; 100(17):1260-2. PubMed ID: 18728283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.
    Vanharanta S; Buchta M; McWhinney SR; Virta SK; Peçzkowska M; Morrison CD; Lehtonen R; Januszewicz A; Järvinen H; Juhola M; Mecklin JP; Pukkala E; Herva R; Kiuru M; Nupponen NN; Aaltonen LA; Neumann HP; Eng C
    Am J Hum Genet; 2004 Jan; 74(1):153-9. PubMed ID: 14685938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
    McWhinney SR; Pilarski RT; Forrester SR; Schneider MC; Sarquis MM; Dias EP; Eng C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5694-9. PubMed ID: 15531530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis of patients with pediatric pheochromocytoma.
    Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
    Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of hereditary head and neck paragangliomas.
    Boedeker CC; Hensen EF; Neumann HP; Maier W; van Nederveen FH; Suárez C; Kunst HP; Rodrigo JP; Takes RP; Pellitteri PK; Rinaldo A; Ferlito A
    Head Neck; 2014 Jun; 36(6):907-16. PubMed ID: 23913591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
    Gaal J; Burnichon N; Korpershoek E; Roncelin I; Bertherat J; Plouin PF; de Krijger RR; Gimenez-Roqueplo AP; Dinjens WN
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1274-8. PubMed ID: 19915015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
    Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites.
    Neumann HP; Sullivan M; Winter A; Malinoc A; Hoffmann MM; Boedeker CC; Bertz H; Walz MK; Moeller LC; Schmid KW; Eng C
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1279-82. PubMed ID: 21613359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas.
    Schiavi F; Savvoukidis T; Trabalzini F; Grego F; Piazza M; Amistà P; Demattè S; Del Piano A; Cecchini ME; Erlic Z; De Lazzari P; Mantero F; Opocher G
    Ann N Y Acad Sci; 2006 Aug; 1073():190-7. PubMed ID: 17102086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple and rapid characterization of novel large germline deletions in SDHB, SDHC and SDHD-related paraganglioma.
    Hoekstra AS; van den Ende B; Julià XP; van Breemen L; Scheurwater K; Tops CM; Malinoc A; Devilee P; Neumann HP; Bayley JP
    Clin Genet; 2017 Apr; 91(4):536-544. PubMed ID: 27485256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene.
    Rich T; Jackson M; Roman-Gonzalez A; Shah K; Cote GJ; Jimenez C
    Fam Cancer; 2015 Dec; 14(4):615-9. PubMed ID: 26162468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.